Navigation Links
New Study Data: JANUVIA™ (sitagliptin) Significantly Reduced Blood Sugar Levels and Was Not Associated with Hypoglycemia in Elderly Patients with Type 2 Diabetes
Date:11/21/2008

style="list-style-type:square; line-height:1.5em; list-style-image: url(/images_v4/bullet_solid2.gif);">
  • Macrovascular Outcomes

    • ADVERSE REACTIONS

    • Clinical Trials Experience

    • Postmarketing Experience

    • DRUG INTERACTIONS

    • Digoxin

    • USE IN SPECIFIC POPULATIONS

    • Pregnancy

    • Nursing Mothers

    • Pediatric Use

    • Geriatric Use

    • OVERDOSAGE

    • DESCRIPTION

    • CLI
      '/>"/>

    Source: PRWeb
    Copyright©2008 Vocus, Inc.
    All rights reserved  

    3

    GOOD

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

    Related medicine news :

    1. STAAR Surgical Forms Team of Leading Ophthalmic Surgeons to Study the Use of Collamer(R) Material for Accommodating Intraocular Lenses
    2. Landmark study defines benefits of early HIV testing and treatment for infected infants
    3. Study identifies causes of bone loss in breast cancer survivors
    4. New Study by BioTrends Highlights Practice Management Shifts Among Canadian Nephrologists
    5. Study Suggests Need for More Aggressive Outpatient Monitoring of Patients Hearts When Cause of Stroke is Unclear
    6. Rutgers researchers study cites media violence as critical risk factor for aggression
    7. Brigham and Womens Researchers Partner with Vocantas to use CallAssure in Clinical Research Study
    8. Analyst Available to Comment on New JUPITER Study That Shows AstraZenecas Crestor Significantly Reduces CV Risk
    9. New Study Finds CO2 Ablative Fractional Resurfacing Safe And Effective For Deep Acne Scarring
    10. Study investigates Gore-tex-type device to stop strokes and mini-strokes
    11. The smart way to study

    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    Related Image:
     New Study Data: JANUVIA™ (sitagliptin) Significantly Reduced Blood Sugar Levels and Was Not Associated with Hypoglycemia in Elderly Patients with Type 2 Diabetes 
    New Study Data: JANUVIA™ (sitagliptin) Significantly Reduced Blood Sugar Levels and Was Not Associated with Hypoglycemia in Elderly Patients with Type 2 Diabetes
    (Date:12/1/2009)... , Amadeus will operate a... Cedar Knolls, NJ (PRWEB) December 1, ... has completed the acquisition of all operating as...der in the development of enterprise governance, r...lutions, from DECIMAL, a corporate performance man...
    (Date:12/1/2009)... , A new mind-body medici...itute (AMI) found that daily meditation, diaphragm...ive, and life-enhancing physical, mental and emoti...verill Park, NY (PRWEB) December 1, 2009 –&n...tudy found that meditation and yoga practices lear...
    (Date:12/1/2009)... , , NEWPORT BEACH, Calif., Dec. 1 /PRN...lling code that insurers will reimburse them for t...n monitor for ,going under, for surgery. ,, Ane...nt brain monitoring is to avoid postop dementia fr...hesiologists have not heard the ,avoid over-medica...
    (Date:12/1/2009)... , , SHENZHEN, China, Dec....ain,Drugstore Ltd. (NYSE: NPD ) ("Nepstar" or "t...n China based on the number of directly operated s...ults for the third quarter ended,September 30, 200...January 2009, Nepstar terminated a voting rights a...
    (Date:12/1/2009)... , CHICAGO A study using functional magnetic res...evealed that adults who were exposed to lead as ch...ere presented today at the annual meeting of the R...What we have found is that no region of the brain ...ad author, Kim Cecil, Ph.D., imaging scientist at ...
    Breaking Medicine News(10 mins):Health News:Xybion Acquires Amadeus, a Leader in Governance, Risk, Compliance and Quality Management (GRC) Solutions 2Health News:Xybion Acquires Amadeus, a Leader in Governance, Risk, Compliance and Quality Management (GRC) Solutions 3Health News:New American Meditation Institute Study Reports Wide-Ranging Health Benefits from Meditation and Yoga 2Health News:New American Meditation Institute Study Reports Wide-Ranging Health Benefits from Meditation and Yoga 3Health News:5 Shocking Reasons Your Brain Isn't Worth Twenty Bucks Exposed 2Health News:China Nepstar Chain Drugstore Reports 92.1% Year-on-Year Increase in Operating Income for Third Quarter 2009 2Health News:China Nepstar Chain Drugstore Reports 92.1% Year-on-Year Increase in Operating Income for Third Quarter 2009 3Health News:China Nepstar Chain Drugstore Reports 92.1% Year-on-Year Increase in Operating Income for Third Quarter 2009 4Health News:China Nepstar Chain Drugstore Reports 92.1% Year-on-Year Increase in Operating Income for Third Quarter 2009 5Health News:China Nepstar Chain Drugstore Reports 92.1% Year-on-Year Increase in Operating Income for Third Quarter 2009 6Health News:China Nepstar Chain Drugstore Reports 92.1% Year-on-Year Increase in Operating Income for Third Quarter 2009 7Health News:China Nepstar Chain Drugstore Reports 92.1% Year-on-Year Increase in Operating Income for Third Quarter 2009 8Health News:China Nepstar Chain Drugstore Reports 92.1% Year-on-Year Increase in Operating Income for Third Quarter 2009 9Health News:China Nepstar Chain Drugstore Reports 92.1% Year-on-Year Increase in Operating Income for Third Quarter 2009 10Health News:China Nepstar Chain Drugstore Reports 92.1% Year-on-Year Increase in Operating Income for Third Quarter 2009 11Health News:China Nepstar Chain Drugstore Reports 92.1% Year-on-Year Increase in Operating Income for Third Quarter 2009 12Health News:China Nepstar Chain Drugstore Reports 92.1% Year-on-Year Increase in Operating Income for Third Quarter 2009 13Health News:Childhood lead exposure causes permanent brain damage 2
    ...irst heart transplant patient whose donor heart wa... The pioneering operation was performed on the ...uth Wales on 20 February after her body rejected h...attached to it. The operation was performed by...
    ...gst Italian scientists to show that high cholester... though more studies to prove the same is welcome....on of male hormones that cause prostate cancer, wh...sk of getting afflicted with cancer The resea...
    ...winner of the prestigious Dada Saheb Phalke Award,...is afternoon. //The superstar had come in the lime...smuggler Veerappan for more than 100 days, about s...ysician Dr Ramana Rao said. Dr Bhujanga Shetty of ...
    ...ods it ahs been found that survival rates followin... three-fold when emergency medical// personnel use... Arizona Sarver Heart Center. Cardiocerebral Res...ael J. Kellum, MD, leading author of the study rep...
    ...in 2000 and was later recommendation for all child... in the rates of pneumonia among young infants. /...ease among children younger than 2 years of age wa...tion rate. But in the present study that was condu...
    ...ases are an urban lifestyle phenomenon, a three-ye... revealed that heart-related problems// are the la...ive leading institutes led by the Byrraju Foundati...se Control (CCDC), the CARE Foundation in India, t...
    Other Medicine News:Health News:Donor Heart Gives Way for Patient’s Own Hear 2Health News:Paramedics save more lives following unconventional rules 2Health News:Mortality Rates Due To Heart Diseases Is High In Rural Areas Too 2
    (Date:11/30/2009)...v. 30 Reportlinker.com announces t...ts catalogue: ,, Cardiac Defibrillators - A Wo...www.reportlinker.com/p0164315/Cardiac-Defibrillato... ,, Cardiovascular disease (CVD) is one of the ...c arrest survivors are prone to arrhythmic disorde...
    (Date:11/30/2009).... 30 Reportlinker.com announces th...s catalogue: ,, Europe Ophthalmic Devices Inve...15 ,, http://www.reportlinker.com/p0166515/Eu...nalysis-and-Forecasts-to-2015.html ,, Europe O...is and Forecasts to 2015 ,, Summary ,, Thi...
    (Date:11/30/2009)...ov. 30 MedQuist Inc....y-enabled clinical documentation services, is feat... Society of North America (RSNA) conference in Chi...duct leverages SpeechQ(TM), the company,s real-tim...by thousands of radiologists. MedQuist has integr...
    Breaking Medicine Technology:Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 2Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 3Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 4Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 5Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 6Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 7Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 8Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 2Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 3Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 4Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 5Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 6Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 7Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 8Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 9Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 10Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 11Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 12Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 13Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 14Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 15Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 16MedQuist Features SpeechQ VTB for Radiology Solution at RSNA Convention 2Binge Drinking Puts the Brain and Life Itself at Risk 60891 1Binge Drinking Puts the Brain and Life Itself at Risk 60891 2Binge Drinking Puts the Brain and Life Itself at Risk 60891 3Dallas Bariatric Surgeon Offers Multiple Options for Patients Considering Weight Loss Surgery in a Rough Economy 60889 1Dallas Bariatric Surgeon Offers Multiple Options for Patients Considering Weight Loss Surgery in a Rough Economy 60889 2Dallas Bariatric Surgeon Offers Multiple Options for Patients Considering Weight Loss Surgery in a Rough Economy 60889 3Hot Peppers and Caffeine Relieve Painful Feet Toe Fungus and Foot Odor 60887 1Hot Peppers and Caffeine Relieve Painful Feet Toe Fungus and Foot Odor 60887 2
    ...maceuticals, Inc. (Nasdaq: ALXA ) today announce...l trial of AZ-004 (Staccato(R) loxapine). This Ph...h bipolar disorder experiencing,acute agitation. ...imary,endpoint of the trial, which was a statistic...ine to the 2-hour post-dose time point, compared t...
    ...lts from a Phase 1/2 study of perifosine in combin...ple myeloma patients relapsed from or refractory t...harmaceuticals, Inc. (Nasdaq: KERX ) today annou...KRX-0401) in combination with bortezomib (+/- dexa...ltiple myeloma. The data was presented earlier to...
    Other Medicine Technology:Alexza's AZ-004 (Staccato(R) Loxapine) Meets Primary Endpoint of Treating Acute Agitation in Patients with Bipolar Disorder in Phase 3 Trial 2Alexza's AZ-004 (Staccato(R) Loxapine) Meets Primary Endpoint of Treating Acute Agitation in Patients with Bipolar Disorder in Phase 3 Trial 3Alexza's AZ-004 (Staccato(R) Loxapine) Meets Primary Endpoint of Treating Acute Agitation in Patients with Bipolar Disorder in Phase 3 Trial 4Alexza's AZ-004 (Staccato(R) Loxapine) Meets Primary Endpoint of Treating Acute Agitation in Patients with Bipolar Disorder in Phase 3 Trial 5Alexza's AZ-004 (Staccato(R) Loxapine) Meets Primary Endpoint of Treating Acute Agitation in Patients with Bipolar Disorder in Phase 3 Trial 6Alexza's AZ-004 (Staccato(R) Loxapine) Meets Primary Endpoint of Treating Acute Agitation in Patients with Bipolar Disorder in Phase 3 Trial 7Alexza's AZ-004 (Staccato(R) Loxapine) Meets Primary Endpoint of Treating Acute Agitation in Patients with Bipolar Disorder in Phase 3 Trial 8Alexza's AZ-004 (Staccato(R) Loxapine) Meets Primary Endpoint of Treating Acute Agitation in Patients with Bipolar Disorder in Phase 3 Trial 9Alexza's AZ-004 (Staccato(R) Loxapine) Meets Primary Endpoint of Treating Acute Agitation in Patients with Bipolar Disorder in Phase 3 Trial 10Keryx Biopharmaceuticals, Inc. Reports Phase 1/2 Data on KRX-0401 (Perifosine) at 50th Annual Meeting of American Society of Hematology 2Keryx Biopharmaceuticals, Inc. Reports Phase 1/2 Data on KRX-0401 (Perifosine) at 50th Annual Meeting of American Society of Hematology 3Keryx Biopharmaceuticals, Inc. Reports Phase 1/2 Data on KRX-0401 (Perifosine) at 50th Annual Meeting of American Society of Hematology 4Keryx Biopharmaceuticals, Inc. Reports Phase 1/2 Data on KRX-0401 (Perifosine) at 50th Annual Meeting of American Society of Hematology 5Keryx Biopharmaceuticals, Inc. Reports Phase 1/2 Data on KRX-0401 (Perifosine) at 50th Annual Meeting of American Society of Hematology 6Keryx Biopharmaceuticals, Inc. Reports Phase 1/2 Data on KRX-0401 (Perifosine) at 50th Annual Meeting of American Society of Hematology 7
    ...to provide the surgeon with surgical solutions for...linically successful P.F.C. Total Knee System intr...f innovation.,Indicated for procedures where mech...cruciate ligament, the cruciate substituting compo...
    BioPro® Uni Knee, Total Resurfacing Preserves Bone Stock
    Alpina® Total Knee System
    OptiMumm™ Smoke Evacuator
    Medicine Products: